Chief Medical Director of RE-Stem
Dr. Wang Tie, holding both a medical doctorate and a master’s degree in economics, serves as the Deputy Chief Engineer of RE-Stem’s research and development center in Los Angeles, USA. He is also the Secretary-General of the Biotechnology and Cellular Application Committee of the Chinese Non-government Medical Institutions Association (CNMIA). Additionally, he holds the position of Deputy Secretary-General of the National Health Service Industry Technology Innovation Strategic Alliance. With over two decades of experience in medical clinical research, Dr. Wang Tie possesses numerous patents in the field of stem cells, particularly pioneering the research on diabetes and liver diseases in China.
In 2014, Dr. Wang Tie was invited to participate in the “2014 China Cell Therapy Conference” organized jointly by Bioon.com, the National Stem Cell Engineering and Technology Research Center, and the National Engineering Research Center for Cell Products. He discussed the latest research progress in cell therapy technology, offered insights into the future prospects of the field. He also shared his expertise on cancer risk testing at the Golden Glow Annual Thanksgiving Gala co-hosted by RE-Stem Biotech and Award Jewellery (International).
In 2015, Dr. Wang was invited to attend the 13th Conference on Stem cells:therapeutic outlook for nervous system disorders hosted by the International Association of Neurorostoratology and co-organized by Capital Medical University, RE-Stem Biotech, and the Beijing Institute of Disorders. There, he engaged in discussions with experts on the latest scientific achievements and clinical applications of autologous stem cells in the treatment of bone and joint diseases, Parkinson’s disease, and more.
